Breast cancer cells can stimulate the de novo secretion of CCL5 from mesenchymal stem cells within the tumor stroma, which then acts in a paracrine fashion on cancer cells to enhance their motility, invasion, and metastasis [26]. Here, CCL5 is linked to neoplasm.